| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022973 |
| Receipt No. | R000026483 |
| Scientific Title | Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2022/09/24 (Ver. 5) |
| Basic information | ||
| Public title | Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. | |
| Acronym | Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. | |
| Scientific Title | Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. | |
| Scientific Title:Acronym | Prospective study on the effectiveness assessment of Indocyanine Green Lymphography and Lymphatic Surgery for lymphedema and lymphatic disease. | |
| Region |
|
|
| Condition | |||||
| Condition | Lymphedema and lymphatic disease | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Using indocyanine green lymphography and lymphoscintigraphy, ultrasonography(including elastgraphy), softmeasure to investigate the pathology and the effectiveness of surgical remedies in lymphedema patients by analyzing pre-, intra-, and post-operative lymphatic assessments, comparing pre and postoperative changes, and assessing the associated clinical symptoms. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | We analyze the assesment pre-operation and every 6 month. |
| Key secondary outcomes | Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness/softmeasure); echogram(especially collecting lymphatic vessels and elastgrraphy), CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | indocyanine green lymphography
lymph vessel assessment |
|
| Interventions/Control_2 | lymphoscintigraphy
lymph vessel assessment |
|
| Interventions/Control_3 | Echography and the assessment of collecting lymphatic vessels | |
| Interventions/Control_4 | Elastography and tonometer(softmeasure) | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All Subjects included in this study are lymphedema and lymphatic disease patients undergoing surgical treatment at our department who have been fully informed of all clinical tests, questionnaires, surgical treatments, and the purpose and analysis of this study and have all consented in writing. No age restriction and exclusion criteria were set. | |||
| Key exclusion criteria | none | |||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saiseikai Kawaguchi General Hospital | ||||||
| Division name | Department of Lymphatic and Reconstructive Surgery | ||||||
| Zip code | 332-8558 | ||||||
| Address | 5-11-5, Nishikawaguchi, Kawaguchi-shi, Saitama, Japan | ||||||
| TEL | 048-253-1551 | ||||||
| mihara-m@saiseikai.gr.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saiseikai Kawaguchi General Hospital | ||||||
| Division name | Financial and legal department | ||||||
| Zip code | 332-8558 | ||||||
| Address | 5-11-5 Nishikawaguchi, Kawaguchi-shi, Saitama, Japan | ||||||
| TEL | 0482531551 | ||||||
| Homepage URL | |||||||
| zaimuhoumu@saiseikai.gr.jp | |||||||
| Sponsor | |
| Institute | Saiseikai Kawaguchi General Hospital. Department of lymphatic and reconstructive surgery. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Saiseikai Kawaguchi General Hospital |
| Address | Nishi-kawaguchi 5-11-5, Kawaguchi-shi, Saitamaken, Japan |
| Tel | 048-253-1551 |
| mihara.plasticsurgery@gmail.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 済生会川口総合病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.mominoki-shinryosho.jp/cellulitis/evidence/ |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://www.mominoki-shinryosho.jp/cellulitis/evidence/ | ||||||
| Number of participants that the trial has enrolled | 200 | ||||||
| Results | Preparing data | ||||||
| Results date posted |
|
||||||
| Results Delayed |
|
||||||
| Results Delay Reason | Preparing data | ||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Preparing data | ||||||
| Participant flow | Preparing data | ||||||
| Adverse events | Preparing data | ||||||
| Outcome measures | Preparing data | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026483 |